tiprankstipranks
Trending News
More News >
Par Drugs and Chemicals Limited (IN:PAR)
:PAR
India Market

Par Drugs and Chemicals Limited (PAR) Income Statement

Compare
1 Followers

Par Drugs and Chemicals Limited Income Statement

Last quarter (Q1 2024), Par Drugs and Chemicals Limited's total revenue was ₹226.06M, a decrease of -1.43% from the same quarter last year. In Q1, Par Drugs and Chemicals Limited's net income was ₹25.33M. See Par Drugs and Chemicals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 956.40M₹ 950.95M₹ 742.00M₹ 598.80M₹ 550.97M
Gross Profit
₹ 609.88M₹ 286.90M₹ 243.36M₹ 224.43M₹ 154.70M
Operating Expenses
₹ 58.29M₹ 141.38M₹ 116.81M₹ 92.81M₹ 90.18M
Depreciation and Amortization
₹ 34.36M₹ 32.33M₹ 32.81M₹ 28.19M₹ 27.62M
EBITDA
₹ 229.53M₹ 182.07M₹ 162.55M₹ 181.88M₹ 94.49M
Operating Income
₹ 551.59M₹ 149.74M₹ 129.74M₹ 131.94M₹ 66.87M
Other Income/Expenses
₹ -356.42M₹ -346.21M₹ -288.31M₹ 15.64M₹ -4.60M
Pretax Income
₹ 195.17M₹ 150.79M₹ 127.03M₹ 147.26M₹ 59.92M
Net Income
₹ 145.01M₹ 113.34M₹ 92.13M₹ 116.11M₹ 47.65M
Per Share Metrics
Basic EPS
₹ 11.78₹ 9.21₹ 7.49₹ 18.87₹ 7.75
Diluted EPS
₹ 11.78₹ 9.21₹ 7.49₹ 18.87₹ 7.75
Weighted Average Shares Outstanding
12.31M 12.30M 12.30M 6.15M 6.15M
Weighted Average Shares Outstanding (Diluted)
12.30M 12.30M 12.30M 6.15M 6.15M
Currency in INR

Par Drugs and Chemicals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis